Skip to main content
. Author manuscript; available in PMC: 2022 Dec 2.
Published in final edited form as: Stem Cell Rev Rep. 2022 Aug 11;18(8):2833–2851. doi: 10.1007/s12015-022-10437-6

Fig. 5.

Fig. 5

Anti-AR drug resistance caused by phenotype plasticity. Because of ADT, AR-V7 is produced by mRNA abnormal alternative splicing, leading to a protein that lacks ligand binding domain, but conserves DNA binding and transactivation domains. Androgen-independent AR-V7 activates the transcription of a new set of genes producing epithelial plasticity, were TGF-β is a critical factor inducing the production of neuroendocrine, mesenchymal and stem cells showing resistance to anti-AR therapy